Different cell populations of renal cell carcinoma
Prostate stem cells are CD133/ABCG2/EpCAM-positive, aldefluor-low, and can regenerate prostate epithelial cell cultures
Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the prostate
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis
Accumulation of progenitor cells in the luminal epithelial cell layer in a targeted Pten knockout mouse prostate cancer model
Target antigen and regulatory T cell in experimental autoimmune prostatitis (EAP)
Bladder cancer prognosis in relationship to variation in 108 genes coding for proteins involved in inflammatory pathways
Tumor-associated trypsin inhibitor (TATI, SPINK1), but not trypsinogen-1, is associated with outcome after radical prostatectomy as evaluated by oligonucleotide and tissue microarrays in prostate cancer
Discovering an organ-specific cell permeable peptide as an imaging probe for detecting metastasized bladder cancer
TMPRSS2-ERG rearrangement in prostate cancer
Clusterin is a very short half-life, poly-ubiquitinated protein controlling cell growth and proliferation in prostate cancer metastatic cells
Epigenetic induction of Igf2 and H19 with choline and methionine deficiency in the mouse prostate
A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model
Pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, RANKL, and PTHrP conjugated covalently with SATA to bcl-2 phosphorylating agent vinorelbine- tartrate eradicated osteo-blastic, and osteolytic skeletal metastases of hormone refractory prostate cancer (mHRPC) by inducing ADCC, AMP, type I,II,III PCD, and inhibiting proliferation of tumor associated, and bone microvascular endothelial cells
Isolation of prostate stem/progenitor cells using a sphere forming assay
The dysregulation of three-dimensional specific genes play a significant role in prostate cancer development
Twist, a novel androgen-regulated gene is a target for Nkx3.1 in prostate cancer cells
Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence
SOCS-3 is upregulated by androgens in prostate cancer cells and exerts inhibitory effects on ar-mediated proliferation
Identifying molecular factors in androgen receptor nucleocytoplasmic trafficking
Human prostate endothelial cells as a first-line target for androgens
Prostate cancer cell proliferation involves cell cycle phase-dependent interaction of androgen receptor with the enzymes of DNA synthesis
Prohibitin and coflilin are smad-indepen-dent mediators of TGF-β signaling in prostate cancer cells
Testosterone stimulated growth of the rat prostate may be driven by tissue hypoxia and HIF-1α
VHL gene mutations in renal cancer are not predictive of hypoxic gene regulation or dissemination of cancer cells
Hypoxia regulates tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis in normal prostate epithelial cells
Prostate cancer cells secrete IL-4 an induce an M2 phenotype in infiltrating macrophages
Characterization of prostate specific inflammation in an inducible mouse model
Dendritic cell prostate cancer vaccine is enhanced by inhibiting the SH2-domain-containing phosphatase, SHP-1
Sutent® treatment leads to decreased uptake of mAb cG250 in RCC
Molecular identification of microorganisms associated with prostate cancer
Hedgehog signaling and proliferative inflammatory atrophy
RNASEL and its role in Irish prostate cancer patients
Decreased Nrf2 expression and increased reactive oxygen species (ROS) in prostate cancer
Study of bladder cancer susceptibility conferred by 309 SNPs in 109 genes participating in inflammatory pathways
Expression of angiogenic factors in an orthotopic rat prostate tumour and in the surrounding non-malignant prostate tissue
Smarcc1 expression is upregulated in prostate cancer and positively correlated with tumor recurrence and dedifferentiation
SOCS-3 expression is regulated by fibro-blast growth factor (FGF)-2 in prostate cancer cell lines
Molecular characterization and expansion in vitro of clonogenic human prostate cancer cells
An analysis of the role of Cyr61, a member of the CCN family, in prostate cancer
Alpha-T-catenin (CTNNA 3) displays tumour specific monoallelic expression in urothelial carcinoma of the bladder (UCB)
Cytoplasmic E-cadherin (cdh1) staining is an independent predictor of time to recurrence in bladder cancer
P-Mark
GATA-6 mediates human bladder smooth muscle differentiation
DNA vaccination for prostate cancer
ERβ selective agonists a therapeutic opportunity for benign prostatic hyperplasia
Prostate carcinogenesis in a PSMA transgenic prostate tissue recombinant model
Serenoa repens extract induces cytosolic lipid accumulation in a panel of cancer cell lines, but is able to activate the intrinsic apoptotic pathways selectively in prostate cancer cells
Regulation of PBX 3 in prostate cancer
Global gene expression analysis for identification of genes involved in stromal androgen receptor signalling and regulation of human prostatic stem cells
Regulation of hAG-2 and hAG-3 transcripts in prostate cancer
2D-DIGE as a strategy to identify differentially expressed serum proteins between different grades of prostate cancer
Proteomic profiling of effect of prostate specific antigen (PSA) in prostate cancer cells
Brain derived metastatic prostate cancer DU-145 cells are effectively inhibited in vitro by guava (Psidium gujava L.) leaf extracts
β2-microglobu l in-mediated signaling drives prostate cancer bone metastasis
Substituted titanocenes
Transcriptional regulation of E-cadherin (CDH1) in urothelial carcinoma of the bladder - the key players
Titanocene analogues induce apoptosis in the PWR-1E prostate epithelial cell line in a time and dose dependent manner
ADAM 15 disintegrin plays a critical role in prostate cancer metastasis by modulating metastatic- associated proteins and regulating endothelial interactions
Combined targeting of Androgen Receptor and Protein Kinase A signaling pathways in prostate cancer cells
Effects of docetaxel and novel titanocene analogues on cell death in prostate cancer following downregulation of Id-1
Determination of novel urinary biomar-kers of prostate cancer using a 2D-DIGE proteome platform
PSA testing and prostate cancer diagnosis in the Republic of Ireland
Improved targeting of contrast agent microbubbles to αvβ3 integrin sites in the prostate
A novel high throughput screen identifies senescence-inducing activity of diaziqu- one in prostate cancer cells
Prodrug activation therapy kills prostate cancer cells in a three-dimensional culture model
A lentivirus vector system to track prostate cancer stem cell differentiation
Alterations of TGFβ signaling in a sub-population of stromal cells can promote prostate tumorigenesis
Cholesterol sensitivity of endogenous and myristoylated akt
Proteomic analyses of human prostate cancer progression cell lines
Protective effect of alfuzosin on neurogenic inflammatory responses and nociception in the rat lower urinary tract
Differential expression of the TSC22 domain family of transcription factors in normal prostate and prostate cancer
The International Bladder Cancer Bank -models for sharing tissue resources
TGF-beta1 downregulates Cx43 and restrains functional syncytia formation in cultured human bladder smooth muscle cells
Detection of TMPRSS2-ERG fusion transcripts and PCA3 in urinary sediments may improve diagnosis of prostate cancer
Up-regulation of TRAG-3 gene, a new predictor for chemotherapeutic resistance, associated with high- stage of bladder cancer
Comparison of the time-resolved fluorescence-based PCA3 test with the Gen-Probe PCA3 test for the detection of prostate cancer cells in urinary sediments
Proteins entrapped in PCa-derived exosomes as a source of novel serum markers
The effects of prostate cancer cell- derived soluble factors on the migration of prostate stromal cells
Mass spectroscopy imaging of prostate cancer tissue-a non target approach for protein biomarker discovery
Red fluorescent tdTomato reporter gene in the Fisher F344/AY-27 bladder cancer model
Preclinical evaluation of the prostate-specific oncolytic adenovirus Ad [I/PPT-E1A],
Carbonanotubes filled with carboplatin - a nanocarrier mediates inhibition of bladder cancer proliferation
Application of solifenacin in children with neurogenic bladder below 6 years of age
Endoscopic augmentation of neurogenic bladder in children with botulinum-A toxin
In vitro molecular evidence for better therapeutic efficacy of 2-methoxyestra-diol and endothelin a receptor antagonists combination in prostate cancer
DD3/PCA3 and AMACR in archived prostate biopsies
Silencing of the Nox4 NADP(H) oxidase enhances chemosensitivity of renal cell carcinoma to cisplatin
Hypoxia-inducible suicide gene therapy approach radiosensitises prostate cancer cells
IGFBP-3 inhibits prostate tumour cell adhesion, migration and invasion
An untested and new approach towards the development of glycosylation-related cancer signatures
Cystoscopy for in vivo tumor assessment in the orthotopic rat bladder urothelial cell carcinoma model
Role of microenvironmental VEGF distribution in human prostate angiogenesis
A bioinformatics approach to identify candidate apoptotic genes which may be the subject of epigenetic control in prostate cancer
Upregulation of muscarinic M2 receptors in detrusor muscle of patients with interstitial cystitis
Effects of coactivator CBP and androgen receptor on estrogen receptor beta in prostate cancer cell lines
Validation of self-reported race using the sequenom massarray compact system to quantitatively determine genomic ancestry
Stem cell characteristics of human prostate cancer cell lines
Cholesterol transport protein in therapeutic targeting of advanced prostate cancer
Identification of serum amyloid alpha by proteome analysis as a specific biomarker in serum of patients with renal cell carcinomas
In vitro evaluation of combined effects of conventional and new cytotoxic agents against a hormone-refractory prostate cancer (HRPC) cell line
Detection of human telomerase reverse transcriptase (hTERT) in superficial high-grade bladder cancer before and after BCG instillations
Urine fish (U-FISH) analysis as a diagnostic tool for recurrent bladder cancer
Copy number aberrations in prostate cancer cell lines by single nucleotide polymorphism array analysis
A role for the heparin-binding cytokines pleiotrophin and midkine in prostate cancer?
DHT rescues prostate cancer cells from Doxazocin induced apoptosis
Genome-wide copy number profiling and TNM staging of renal cell tumors
Radiolabelled Bothbesin analogues
Does dexamethasone work in androgen-independent prostate cancer (AIPC) by modulation of interleukin-8?
Role of noggin in osteolytic bone metastasis
A self-directed learning package in bladder cancer pathology using virtual microscopy
Knockdown of Mitomycin C resistance by Ras siRNA in vitro
Downregulation of FYN tyrosine kinase in prostate cancer by chromosomal deletion and promoter hypermethylation
Oct4 expression in benign and prostate cancer neuroendocrine cells
Chemotherapy combinations after docet- axel refractoriness in HRPC patients
Enhanced expression of hypoxia markers in cell lines and in clinical specimens of malignant prostate tissue
Effects of epigallocatechin-3-gallate (EGCG) on cell growth and apoptosis of prostate cancer lines and its interactions with dihydrotestosterone (DHT)
Transforming growth factor-beta (TGFβ) elicits differentiation of prostatic stroma in a lobe-specific manner
Combined treatment with lycopene and vitamin E; what is the optimal dose for inhibition of prostate cancer development in nude mice?
Lycopene inhibits the growth of various androgen (in) dependent cell lines in vitro
Identification of putative stem cells in human prostate cancer xenografts
New cryopreservation method for human prostate cancer xenografts
Towards the identification of PCA3 RNA- binding proteins
Progression into androgen independent prostate cancer alters endothelial cell gene expression in vitro
Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue after castration therapy
Decreased stroma androgen receptor staining in tumor and in surrounding non-malignant tissue is related to gleason score, tumor size, metastasis and outcome in prostate cancer
Prostate cancer stem cells
Non-invasive detection of bladder cancer by measurement of tumor-related transcript markers in urine
Soluble growth factors or bone micro-environment promote epithelial to mesenchymal transition and bone metastases in human prostate cancer
AUTHOR INDEX